In GC, it includes the cancer drivers WHSC1, CBFB, RUNX1, EZH2 (male, female log2FC/FDR = 1.6/2.1e-10, 1.9/6e-7), MET, and CARD11. In TC, we recapitulated MET (2.6/2.2e-10, 2.5/3.1e-25) and RUNX1, plus CCND1, CDKN1A, ERBB3, FOXQ1, FGFR3, and the known oncogene in TC ZCCHC12 (Wang et al., 2017). This evidence concerns the gene FGFR3 and gastric cancer.